178 related articles for article (PubMed ID: 7729720)
1. [Insulin resistance in the pathogenesis of polycystic ovarian disease (PCOD)].
Jakowicki J
Ginekol Pol; 1994 Oct; 65(10):582-6. PubMed ID: 7729720
[TBL] [Abstract][Full Text] [Related]
2. Polycystic ovarian disease.
Barbieri RL
Annu Rev Med; 1991; 42():199-204. PubMed ID: 2035966
[TBL] [Abstract][Full Text] [Related]
3. [Polycystic ovarian disease. 1. The current data on its etiology and pathogenesis].
Rachev E
Akush Ginekol (Sofiia); 1999; 38(2):42-5. PubMed ID: 10730388
[No Abstract] [Full Text] [Related]
4. Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome.
Poretsky L; Piper B
Obstet Gynecol; 1994 Oct; 84(4):613-21. PubMed ID: 8090402
[TBL] [Abstract][Full Text] [Related]
5. Hyperandrogenism, insulin resistance and acanthosis nigricans. 10 years of progress.
Barbieri RL
J Reprod Med; 1994 May; 39(5):327-36. PubMed ID: 8064699
[TBL] [Abstract][Full Text] [Related]
6. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z
Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
[TBL] [Abstract][Full Text] [Related]
7. Obesity and the polycystic ovary syndrome.
Gambineri A; Pelusi C; Vicennati V; Pagotto U; Pasquali R
Int J Obes Relat Metab Disord; 2002 Jul; 26(7):883-96. PubMed ID: 12080440
[TBL] [Abstract][Full Text] [Related]
8. Hyperinsulinemia and ovarian hyperandrogenism. Cause and effect.
Barbieri RL; Hornstein MD
Endocrinol Metab Clin North Am; 1988 Dec; 17(4):685-703. PubMed ID: 3058472
[TBL] [Abstract][Full Text] [Related]
9. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism.
Barbieri RL; Smith S; Ryan KJ
Fertil Steril; 1988 Aug; 50(2):197-212. PubMed ID: 3294042
[TBL] [Abstract][Full Text] [Related]
10. Hyperandrogenism, insulin resistance and hyperinsulinemia as cardiovascular risk factors in diabetes mellitus.
García-Romero G; Escobar-Morreale HF
Curr Diabetes Rev; 2006 Feb; 2(1):39-49. PubMed ID: 18220616
[TBL] [Abstract][Full Text] [Related]
11. Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion.
Geffner ME; Kaplan SA; Bersch N; Golde DW; Landaw EM; Chang RJ
Fertil Steril; 1986 Mar; 45(3):327-33. PubMed ID: 3512314
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian androgen production.
Cara JF
Horm Res; 1994; 42(1-2):49-54. PubMed ID: 7525445
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome and type 2 diabetes mellitus.
De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F
Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
[TBL] [Abstract][Full Text] [Related]
14. The Emerging Role of Chronic Low-Grade Inflammation in the Pathophysiology of Polycystic Ovary Syndrome.
Shorakae S; Teede H; de Courten B; Lambert G; Boyle J; Moran LJ
Semin Reprod Med; 2015 Jul; 33(4):257-69. PubMed ID: 26132930
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.
Dunaif A
Endocr Rev; 1997 Dec; 18(6):774-800. PubMed ID: 9408743
[TBL] [Abstract][Full Text] [Related]
16. Type 2 diabetes and the polycystic ovary syndrome.
Pelusi B; Gambineri A; Pasquali R
Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
[TBL] [Abstract][Full Text] [Related]
17. Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome.
Sozen I; Arici A
Obstet Gynecol Surv; 2000 May; 55(5):321-8. PubMed ID: 10804539
[TBL] [Abstract][Full Text] [Related]
18. Fasting as possible complementary approach for polycystic ovary syndrome: Hope or hype?
Chiofalo B; Laganà AS; Palmara V; Granese R; Corrado G; Mancini E; Vitale SG; Ban Frangež H; Vrtačnik-Bokal E; Triolo O
Med Hypotheses; 2017 Aug; 105():1-3. PubMed ID: 28735644
[TBL] [Abstract][Full Text] [Related]
19. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications.
Nestler JE
Semin Reprod Endocrinol; 1997 May; 15(2):111-22. PubMed ID: 9165656
[TBL] [Abstract][Full Text] [Related]
20. [Genetic aspects of polycystic ovary syndrome].
Jakubowski L
Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
